Atlas Trials

SynAct Pharma Aps

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch SynAct Pharma Aps

RecordFirmDate
A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses (NCT07633288)SynAct Pharma Aps2026-05-01
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis (NCT06671054)SynAct Pharma Aps2024-10-01
A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (NCT05604885)SynAct Pharma Aps2022-11-30
A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment (NCT05516979)SynAct Pharma Aps2022-09-26
A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria (NCT04456816)SynAct Pharma Aps2020-08-31
A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease (NCT04004429)SynAct Pharma Aps2019-08-26

Track SynAct Pharma Aps automatically

Every clearance here is in the API, with alerts when new ones post.